Trials / Completed
CompletedNCT01387854
Observational Study of Patients With Mucopolysaccharidosis (MPS) VI Who Previously Participated in ASB-00-02
A Re-Survey Study of Patients With MPS VI (Maroteaux-Lamy Syndrome) Who Previously Participated in ASB-00-02
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- BioMarin Pharmaceutical · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
There is limited information on the long-term effects of treating patients with MPS VI with Naglazyme® and limited data on the natural history of treated and untreated MPS VI patients. The Re-survey Study ASB-00-03 will assist in understanding the effects of long-term Naglazyme treatment and the natural history of the MPS VI patient population.
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-10-01
- Completion
- 2013-02-01
- First posted
- 2011-07-06
- Last updated
- 2014-04-02
Locations
7 sites across 7 countries: United States, Australia, Brazil, France, Germany, Portugal, United Kingdom
Source: ClinicalTrials.gov record NCT01387854. Inclusion in this directory is not an endorsement.